PMV Pharmaceuticals (NASDAQ:PMVP) vs. Rock Creek Pharmaceuticals (OTCMKTS:RCPIQ) Head to Head Survey

PMV Pharmaceuticals (NASDAQ:PMVP) and Rock Creek Pharmaceuticals (OTCMKTS:RCPIQ) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, earnings, analyst recommendations, profitability, institutional ownership, valuation and risk.

Profitability

This table compares PMV Pharmaceuticals and Rock Creek Pharmaceuticals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
PMV Pharmaceuticals	N/A	-68.98%	-62.70%
Rock Creek Pharmaceuticals	N/A	N/A	N/A

Analyst Ratings

This is a breakdown of current recommendations for PMV Pharmaceuticals and Rock Creek Pharmaceuticals, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PMV Pharmaceuticals	1	0	1	1	2.67
Rock Creek Pharmaceuticals	0	0	0	0	0.00

PMV Pharmaceuticals currently has a consensus target price of $5.00, indicating a potential upside of 352.49%. Given PMV Pharmaceuticals’ stronger consensus rating and higher probable upside, research analysts clearly believe PMV Pharmaceuticals is more favorable than Rock Creek Pharmaceuticals.

Earnings and Valuation

This table compares PMV Pharmaceuticals and Rock Creek Pharmaceuticals”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PMV Pharmaceuticals	N/A	N/A	-$77.74 million	($1.49)	-0.74
Rock Creek Pharmaceuticals	N/A	N/A	N/A	N/A	N/A

Institutional & Insider Ownership

90.2% of PMV Pharmaceuticals shares are held by institutional investors. 7.6% of PMV Pharmaceuticals shares are held by company insiders. Comparatively, 0.9% of Rock Creek Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

PMV Pharmaceuticals beats Rock Creek Pharmaceuticals on 6 of the 8 factors compared between the two stocks.

About PMV Pharmaceuticals

PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. It's lead product candidate is PC14586, a small molecule that corrects mutant p53 protein containing the Y220C mutation and restores wild-type p53 function. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is based in Princeton, New Jersey.

About Rock Creek Pharmaceuticals

Rock Creek Pharmaceuticals, Inc. is an early stage life science company, which engages in the discovery, development, and commercialization of new drugs, formulations, and compounds that provide therapies for chronic and acute inflammatory diseases. It focuses on small molecule therapeutics that exhibit anti-inflammatory pharmacological characteristics. The company was founded by Jonnie R. Williams, Sr. on June 24, 1985 and is headquartered in Sarasota, FL.